CBS 2019
CBSMD教育中心
English

Stenting Left Main

科研文章

荐读文献

Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial Successful bailout stenting strategy against lethal coronary dissection involving left main bifurcation Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial Intravascular ultrasound in the evaluation and treatment of left main coronary artery disease: a consensus statement from the European Bifurcation Club Contemporary Approach to Coronary Bifurcation Lesion Treatment Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes

Original Research2017 May;89(6):955-963.

JOURNAL:Catheter Cardiovasc Interv. Article Link

Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients

Minges KE, Herrin J, Fiorilli PN et al. Keywords: Medicare; health care outcomes; percutaneous coronary intervention; quality improvement; risk stratification

ABSTRACT

OBJECTIVES - To develop a risk model that can be used to identify PCI patients at higher risk of readmission who may benefit from additional resources at the time of discharge.

 

BACKGROUND - A high proportion of patients undergoing PCI are readmitted within 30 days of discharge.

 

METHODS - The sample comprised patients aged 65 years who underwent PCI at a CathPCI Registry®-participating hospital and could be linked with 100% Medicare fee-for-service claims between 01/2007 and 12/2009. The sample (n = 388,078) was randomly divided into risk score development (n = 193,899) and validation (n = 194,179) cohorts. We did not count as readmissions those associated with staged revascularization procedures. Multivariable logistic regression models using stepwise selection models were estimated to identify variables independently associated with all-cause 30-day readmission.

 

RESULTS - The mean 30-day readmission rates for the development (11.36%) and validation (11.35%) cohorts were similar. In total, 19 variables were significantly associated with risk of 30-day readmission (P < 0.05), and model c-statistics were similar in the development (0.67) and validation (0.66) cohorts. The simple risk score based on 14 variables identified patients at high and low risk of readmission. Patients with a score of 13 (15.4% of sample) had more than an 18.5% risk of readmission, while patients with a score 6 (41.9% of sample) had less than an 8% risk of readmission.

 

CONCLUSION - Among PCI patients, risk of readmission can be estimated using clinical factors present at the time of the procedure. This risk score may guide clinical decision-making and resource allocation for PCI patients at the time of hospital discharge. © 2016 Wiley Periodicals, Inc.

 

© 2016 Wiley Periodicals, Inc.